SpayVac® is a humane, non-lethal innovation for control of overabundant, feral or invasive mammalian wildlife.
The Anthropocene is proposed as the current epoch, which is “viewed as the period during which human activity has been the dominant influence on climate and the environment”. Many wildlife species, even if they are considered endangered, are overabundant in the ever-shrinking habitat ranges they occupy.
Overabundant species, even native ones, can reduce biodiversity by monopolizing resources, spreading infectious diseases, and changing species composition or relative abundance.
Click on the links below to learn about SpayVac development in different species.
April 30, 2018. "Twenty Years of SpayVac® Research: Potential Implications for Regulating Feral Horse and Burro Populations in the U.S." was published in Human-Wildlife Interactions: Vol. 1: Iss. , Article 13. You can link to the article here:
April 23, 2018. Madison, WI, USA; Victoria, BC, Canada; and Halifax, NS Canada
SpayVac-for-Wildlife, Inc., announced today an agreement with Immunovaccine, Inc. (TSX:IMV) (OTC:IMMVF) who granted them a license to two proprietary vaccine delivery platforms, VacciMax® and DepoVax™. SpayVac-for-Wildlife, Inc. (SFW Inc.) will use these platforms to develop immunocontraceptive vaccines for use in populations of overabundant, feral and invasive mammals. SFW Inc.’s mission is to commercialize humane birth control tools for these over abundant populations.
SFW Inc. will produce and market SpayVac®, a pZP vaccine, using both of IMV’s proprietary VacciMax and DepoVax platforms. SFW Inc. will have global exclusive rights to use both of these platforms to develop humane, immunocontraceptive vaccines for control of overabundant, feral and invasive wildlife populations.
For more go to our full announcement under Latest News in our Links pages
Sign up to hear from us about progress on SpayVac development.